Physician profile
Brian Elkins
NPI 1366452807
$1,386.40
in general payments reported to CMS, 2019-2025
19 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $178 · 2021: $93.12 · 2022: $135 · 2023: $223 · 2024: $335 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $418.73 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $301.12 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $200.56 | 2019-2025 | Airsupra |
| Astellas Pharma US INC | $92.97 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.25 | 2020-2023 | Jardiance |
| Pfizer INC. | $52.68 | 2020-2025 | |
| Abbvie INC. | $36.27 | 2021-2022 | |
| Abbott Laboratories | $31.83 | 2021-2023 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $28.68 | 2019 | |
| Merck Sharp & Dohme LLC | $25.19 | 2019 | |
| Genentech USA, INC. | $19.29 | 2019 | |
| Axsome Therapeutics, INC. | $17.99 | 2025 | Auvelity |
| Amgen INC. | $17.96 | 2019 | |
| Acadia Pharmaceuticals INC | $15.37 | 2020 | |
| Lundbeck LLC | $14.29 | 2025 | Rexulti |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $14.10 | 2025 | Cologuard Collection Kit |
| Medicure Pharma INC. | $14.08 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.68 | 2022 | |
| Almirall LLC | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Elkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.